The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hypersomnia Drug Market Research Report 2025
Synopsis
Hypersomnia indicates frequent and excessive daytime sleepiness. It becomes necessary for patients suffering from hypersomnia to take short naps in-between the day time and sleep more than 10 hours at night. However, the naps do not provide any relief. Also, patients may feel disoriented and can have difficulty in moving. Due to hypersomnia patients may have restlessness, loss of appetite hallucinations and slow speech.
The global Hypersomnia Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hypersomnia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hypersomnia Drug.
Report Scope
The Hypersomnia Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hypersomnia Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hypersomnia Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Jazz Pharmaceuticals
BIOPROJET
AVADEL PHARMACEUTICALS
GlaxoSmithKline
Pfizer
Theranexus
Fisher & Paykel Healthcare
Drive Medical
Merck
Segment by Type
Provigil
Xyrem
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hypersomnia Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Hypersomnia indicates frequent and excessive daytime sleepiness. It becomes necessary for patients suffering from hypersomnia to take short naps in-between the day time and sleep more than 10 hours at night. However, the naps do not provide any relief. Also, patients may feel disoriented and can have difficulty in moving. Due to hypersomnia patients may have restlessness, loss of appetite hallucinations and slow speech.
The global Hypersomnia Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hypersomnia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hypersomnia Drug.
Report Scope
The Hypersomnia Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hypersomnia Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hypersomnia Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Jazz Pharmaceuticals
BIOPROJET
AVADEL PHARMACEUTICALS
GlaxoSmithKline
Pfizer
Theranexus
Fisher & Paykel Healthcare
Drive Medical
Merck
Segment by Type
Provigil
Xyrem
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hypersomnia Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypersomnia Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Provigil
1.2.3 Xyrem
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hypersomnia Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hypersomnia Drug Market Perspective (2019-2030)
2.2 Hypersomnia Drug Growth Trends by Region
2.2.1 Global Hypersomnia Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hypersomnia Drug Historic Market Size by Region (2019-2024)
2.2.3 Hypersomnia Drug Forecasted Market Size by Region (2025-2030)
2.3 Hypersomnia Drug Market Dynamics
2.3.1 Hypersomnia Drug Industry Trends
2.3.2 Hypersomnia Drug Market Drivers
2.3.3 Hypersomnia Drug Market Challenges
2.3.4 Hypersomnia Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hypersomnia Drug Players by Revenue
3.1.1 Global Top Hypersomnia Drug Players by Revenue (2019-2024)
3.1.2 Global Hypersomnia Drug Revenue Market Share by Players (2019-2024)
3.2 Global Hypersomnia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hypersomnia Drug Revenue
3.4 Global Hypersomnia Drug Market Concentration Ratio
3.4.1 Global Hypersomnia Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypersomnia Drug Revenue in 2023
3.5 Hypersomnia Drug Key Players Head office and Area Served
3.6 Key Players Hypersomnia Drug Product Solution and Service
3.7 Date of Enter into Hypersomnia Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypersomnia Drug Breakdown Data by Type
4.1 Global Hypersomnia Drug Historic Market Size by Type (2019-2024)
4.2 Global Hypersomnia Drug Forecasted Market Size by Type (2025-2030)
5 Hypersomnia Drug Breakdown Data by Application
5.1 Global Hypersomnia Drug Historic Market Size by Application (2019-2024)
5.2 Global Hypersomnia Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hypersomnia Drug Market Size (2019-2030)
6.2 North America Hypersomnia Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hypersomnia Drug Market Size by Country (2019-2024)
6.4 North America Hypersomnia Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hypersomnia Drug Market Size (2019-2030)
7.2 Europe Hypersomnia Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hypersomnia Drug Market Size by Country (2019-2024)
7.4 Europe Hypersomnia Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hypersomnia Drug Market Size (2019-2030)
8.2 Asia-Pacific Hypersomnia Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hypersomnia Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Hypersomnia Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hypersomnia Drug Market Size (2019-2030)
9.2 Latin America Hypersomnia Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hypersomnia Drug Market Size by Country (2019-2024)
9.4 Latin America Hypersomnia Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hypersomnia Drug Market Size (2019-2030)
10.2 Middle East & Africa Hypersomnia Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hypersomnia Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Hypersomnia Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Hypersomnia Drug Introduction
11.1.4 Teva Revenue in Hypersomnia Drug Business (2019-2024)
11.1.5 Teva Recent Development
11.2 Jazz Pharmaceuticals
11.2.1 Jazz Pharmaceuticals Company Detail
11.2.2 Jazz Pharmaceuticals Business Overview
11.2.3 Jazz Pharmaceuticals Hypersomnia Drug Introduction
11.2.4 Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2019-2024)
11.2.5 Jazz Pharmaceuticals Recent Development
11.3 BIOPROJET
11.3.1 BIOPROJET Company Detail
11.3.2 BIOPROJET Business Overview
11.3.3 BIOPROJET Hypersomnia Drug Introduction
11.3.4 BIOPROJET Revenue in Hypersomnia Drug Business (2019-2024)
11.3.5 BIOPROJET Recent Development
11.4 AVADEL PHARMACEUTICALS
11.4.1 AVADEL PHARMACEUTICALS Company Detail
11.4.2 AVADEL PHARMACEUTICALS Business Overview
11.4.3 AVADEL PHARMACEUTICALS Hypersomnia Drug Introduction
11.4.4 AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2019-2024)
11.4.5 AVADEL PHARMACEUTICALS Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Hypersomnia Drug Introduction
11.5.4 GlaxoSmithKline Revenue in Hypersomnia Drug Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Hypersomnia Drug Introduction
11.6.4 Pfizer Revenue in Hypersomnia Drug Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Theranexus
11.7.1 Theranexus Company Detail
11.7.2 Theranexus Business Overview
11.7.3 Theranexus Hypersomnia Drug Introduction
11.7.4 Theranexus Revenue in Hypersomnia Drug Business (2019-2024)
11.7.5 Theranexus Recent Development
11.8 Fisher & Paykel Healthcare
11.8.1 Fisher & Paykel Healthcare Company Detail
11.8.2 Fisher & Paykel Healthcare Business Overview
11.8.3 Fisher & Paykel Healthcare Hypersomnia Drug Introduction
11.8.4 Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2019-2024)
11.8.5 Fisher & Paykel Healthcare Recent Development
11.9 Drive Medical
11.9.1 Drive Medical Company Detail
11.9.2 Drive Medical Business Overview
11.9.3 Drive Medical Hypersomnia Drug Introduction
11.9.4 Drive Medical Revenue in Hypersomnia Drug Business (2019-2024)
11.9.5 Drive Medical Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Hypersomnia Drug Introduction
11.10.4 Merck Revenue in Hypersomnia Drug Business (2019-2024)
11.10.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Hypersomnia Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Provigil
Table 3. Key Players of Xyrem
Table 4. Key Players of Others
Table 5. Global Hypersomnia Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Hypersomnia Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Hypersomnia Drug Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Hypersomnia Drug Market Share by Region (2019-2024)
Table 9. Global Hypersomnia Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Hypersomnia Drug Market Share by Region (2025-2030)
Table 11. Hypersomnia Drug Market Trends
Table 12. Hypersomnia Drug Market Drivers
Table 13. Hypersomnia Drug Market Challenges
Table 14. Hypersomnia Drug Market Restraints
Table 15. Global Hypersomnia Drug Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Hypersomnia Drug Market Share by Players (2019-2024)
Table 17. Global Top Hypersomnia Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypersomnia Drug as of 2023)
Table 18. Ranking of Global Top Hypersomnia Drug Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Hypersomnia Drug Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hypersomnia Drug Product Solution and Service
Table 22. Date of Enter into Hypersomnia Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hypersomnia Drug Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Hypersomnia Drug Revenue Market Share by Type (2019-2024)
Table 26. Global Hypersomnia Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Hypersomnia Drug Revenue Market Share by Type (2025-2030)
Table 28. Global Hypersomnia Drug Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Hypersomnia Drug Revenue Market Share by Application (2019-2024)
Table 30. Global Hypersomnia Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Hypersomnia Drug Revenue Market Share by Application (2025-2030)
Table 32. North America Hypersomnia Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Hypersomnia Drug Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Hypersomnia Drug Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Hypersomnia Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Hypersomnia Drug Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Hypersomnia Drug Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Hypersomnia Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Hypersomnia Drug Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Hypersomnia Drug Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Hypersomnia Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Hypersomnia Drug Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Hypersomnia Drug Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Hypersomnia Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Hypersomnia Drug Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Hypersomnia Drug Market Size by Country (2025-2030) & (US$ Million)
Table 47. Teva Company Detail
Table 48. Teva Business Overview
Table 49. Teva Hypersomnia Drug Product
Table 50. Teva Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)
Table 51. Teva Recent Development
Table 52. Jazz Pharmaceuticals Company Detail
Table 53. Jazz Pharmaceuticals Business Overview
Table 54. Jazz Pharmaceuticals Hypersomnia Drug Product
Table 55. Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)
Table 56. Jazz Pharmaceuticals Recent Development
Table 57. BIOPROJET Company Detail
Table 58. BIOPROJET Business Overview
Table 59. BIOPROJET Hypersomnia Drug Product
Table 60. BIOPROJET Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)
Table 61. BIOPROJET Recent Development
Table 62. AVADEL PHARMACEUTICALS Company Detail
Table 63. AVADEL PHARMACEUTICALS Business Overview
Table 64. AVADEL PHARMACEUTICALS Hypersomnia Drug Product
Table 65. AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)
Table 66. AVADEL PHARMACEUTICALS Recent Development
Table 67. GlaxoSmithKline Company Detail
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Hypersomnia Drug Product
Table 70. GlaxoSmithKline Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)
Table 71. GlaxoSmithKline Recent Development
Table 72. Pfizer Company Detail
Table 73. Pfizer Business Overview
Table 74. Pfizer Hypersomnia Drug Product
Table 75. Pfizer Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Theranexus Company Detail
Table 78. Theranexus Business Overview
Table 79. Theranexus Hypersomnia Drug Product
Table 80. Theranexus Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)
Table 81. Theranexus Recent Development
Table 82. Fisher & Paykel Healthcare Company Detail
Table 83. Fisher & Paykel Healthcare Business Overview
Table 84. Fisher & Paykel Healthcare Hypersomnia Drug Product
Table 85. Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)
Table 86. Fisher & Paykel Healthcare Recent Development
Table 87. Drive Medical Company Detail
Table 88. Drive Medical Business Overview
Table 89. Drive Medical Hypersomnia Drug Product
Table 90. Drive Medical Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)
Table 91. Drive Medical Recent Development
Table 92. Merck Company Detail
Table 93. Merck Business Overview
Table 94. Merck Hypersomnia Drug Product
Table 95. Merck Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)
Table 96. Merck Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypersomnia Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hypersomnia Drug Market Share by Type: 2023 VS 2030
Figure 3. Provigil Features
Figure 4. Xyrem Features
Figure 5. Others Features
Figure 6. Global Hypersomnia Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Hypersomnia Drug Market Share by Application: 2023 VS 2030
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Hypersomnia Drug Report Years Considered
Figure 12. Global Hypersomnia Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Hypersomnia Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Hypersomnia Drug Market Share by Region: 2023 VS 2030
Figure 15. Global Hypersomnia Drug Market Share by Players in 2023
Figure 16. Global Top Hypersomnia Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypersomnia Drug as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Hypersomnia Drug Revenue in 2023
Figure 18. North America Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Hypersomnia Drug Market Share by Country (2019-2030)
Figure 20. United States Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Hypersomnia Drug Market Share by Country (2019-2030)
Figure 24. Germany Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Hypersomnia Drug Market Share by Region (2019-2030)
Figure 32. China Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Hypersomnia Drug Market Share by Country (2019-2030)
Figure 40. Mexico Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Hypersomnia Drug Market Share by Country (2019-2030)
Figure 44. Turkey Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Teva Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)
Figure 47. Jazz Pharmaceuticals Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)
Figure 48. BIOPROJET Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)
Figure 49. AVADEL PHARMACEUTICALS Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)
Figure 51. Pfizer Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)
Figure 52. Theranexus Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)
Figure 53. Fisher & Paykel Healthcare Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)
Figure 54. Drive Medical Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)
Figure 55. Merck Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
